By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

American Society of Clinical Oncology 

225 Reinekers Lane
Suite 650
Alexandria  Virginia  22314  U.S.A.
Phone: 703-299-0150 Fax: 703-299-1044


SEARCH JOBS








Company News
TRACON Pharmaceuticals, Inc. (TCON) Announces Positive Phase 1b Results For TRC105 In Combination With Inlyta (Axitinib) At The ASCO 2015 Genitourinary Cancers Symposium 3/2/2015 7:06:30 AM
Argos Therapeutics, Inc. (ARGS) Announces Update On Phase 3 ADAPT Trial To Be Presented During 2015 ASCO Genitourinary Cancers Symposium 2/27/2015 7:14:23 AM
Cancer Genetics, Inc. (CGIX) To Present New Data On Identification Of Genomic Changes That Predict Both Metastasis And Site Of Metastasis In Kidney Cancer At The 2015 American Society of Clinical Oncology Genitourinary Cancers Symposium 2/24/2015 7:47:10 AM
Progenics Pharmaceuticals, Inc. (PGNX) To Present Full Phase 2 Data For PSMA ADC At The 2015 American Society of Clinical Oncology GU Symposium 2/24/2015 7:14:32 AM
TRACON Pharmaceuticals, Inc. (TCON) Announces Upcoming Presentation Of Results From A Clinical Trial Of TRC105 In Patients With Renal Cell Carcinoma At The American Society of Clinical Oncology 2015 Genitourinary Cancers Symposium 2/20/2015 7:29:06 AM
Acceleron Pharma TO Present New Dalantercept Clinical Data At The American Society of Clinical Oncology 2015 Genitourinary Cancers Symposium 2/19/2015 12:20:35 PM
The American Society of Clinical Oncology Recognizes Gensignia's Research In Lung Cancer Screening 1/23/2015 11:07:07 AM
PharmaEngine, Inc. Announces Phase 2 PEPCOL Study Presented At The 2015 American Society of Clinical Oncology GI Of PEP02 (MM-398) In Combination With 5-FU/LV In Unresectable Metastatic Colorectal Cancer 1/21/2015 10:58:16 AM
Merrimack Pharmaceuticals Inc. (MACK) Presents Additional Analyses Of Phase 3 MM-398 NAPOLI-1 Study At The American Society of Clinical Oncology 2015 Gastrointestinal Cancers Symposium 1/20/2015 6:53:46 AM
PharmaEngine, Inc. Announces Expanded Analyses Of Phase 3 MM-398 NAPOLI-1 Study Presented At The 2015 American Society of Clinical Oncology GI Substantiate The Positive Results Of MM-398 In Combination With 5-FU/LV 1/19/2015 11:14:02 AM
12345678910...
//-->